Merilog Patient Assistance Program

(insulin aspart-szjj)

Key Takeaways

  1. Merilog® (insulin aspart-szjj injection) is a rapid-acting insulin analog approved to improve glycemic control in adults and pediatric patients with diabetes mellitus.
  2. Merilog is the first FDA-approved rapid-acting insulin biosimilar in the United States and is biosimilar to NovoLog® (insulin aspart).
  3. Merilog does not carry an FDA Boxed Warning. Still, it has important safety considerations, including the risks of severe hypoglycemia, hypersensitivity reactions, medication errors, and low potassium levels.
  4. Prescription Hope may help eligible individuals access manufacturer-sponsored patient assistance programs that can make Merilog more affordable.

 

Introduction

Managing blood sugar around mealtimes is an important part of diabetes care. Many people with diabetes require rapid-acting insulin to help control blood glucose elevations after eating as part of an individualized treatment plan.

Merilog is a rapid-acting insulin biosimilar approved to improve glycemic control in adults and pediatric patients with diabetes mellitus. Administered shortly before meals, it helps lower post-meal blood sugar levels. It is typically used alongside an intermediate-acting or long-acting insulin as part of a comprehensive diabetes management plan.

Because Merilog is a prescription insulin, treatment costs may vary depending on insurance coverage and pharmacy pricing. Many people searching for a Merilog patient assistance program are researching ways to reduce their prescription costs. Prescription Hope may help eligible patients obtain Merilog at a more affordable cost.

What Is the Merilog Patient Assistance Program?

Understanding Merilog Prescription Assistance

While researching Merilog financial assistance, some patients may have come across the Merilog patient assistance program. But what exactly is a patient assistance program?

Some Pharmaceutical manufacturers have recognized that the cost of their brand-name medications is financially straining for struggling Americans. The pharmaceutical manufacturers have come up with a solution. They routinely launch patient assistance programs. These programs allow qualified patients to access name-brand medication they need at a lower cost than retail. This means that through the pharmaceutical manufacturers, qualified patients can get help paying for Merilog.

The biggest factor that turns patients away from these patient assistance programs is that they have been known for requiring extensive documentation, communication with the manufacturer, and a litany of other administrative responsibilities. This can cause added stress, frustration, and a sense of being overwhelmed by the process.

But Prescription Hope can help!

How Expert Advocates Help Make Merilog More Affordable

Personalized Medication Assistance

Prescription Hope’s Merilog enrollment assistance allows qualified patients access to affordable name-brand medication they need at a low cost.

Our compassionate team of patient advocates understands the difficulty of applying to a prescription assistance program and helps you with any administrative needs during the process. Some of our patient support services include handling forms, documents, and signatures, healthcare provider communication, coordinating with manufacturers, and more.

Ongoing Patient Support

Prescription Hope also offers long-term medication assistance and patient-centered support throughout the time that you are a patient with us. We understand that chronic conditions often require treatment continuity, so we offer services such as refill scheduling, document updates, yearly renewals, program monitoring, and more.

Merilog Price Comparison

vs

Prescription Hope logo

Estimated Retail Price*

$75.85

30-Day Supply

Prescription Hope Price

$70

Per Month, NO Matter The Retail Price

*Source: Drugs.com

Navigating Diabetes Treatment Costs

While diabetes can be a frustrating condition to treat, your ability to get Merilog cost assistance doesn’t have to be. Insulin cost assistance is just one of the modes of prescription cost help that Prescription Hope offers to their qualified patients.

Qualified patients have full access to our patient support services at a simple monthly rate of $70.00 per month, per medication– no matter what medications they get approved for. This price means no hassles, hidden fees, or add-ons.

Even if you don’t qualify for a patient assistance program, we can still help you save. Our team of patient advocates will help you search for other ways to alleviate the financial burden of your intended name-brand medication, such as substitute medications, discount cards, and coupons. But if we can’t help you save money, you pay us nothing!

Merilog Patient Assistance Eligibility

General Eligibility Requirements

Patients looking to enroll in a patient assistance program for Merilog need to understand Merilog patient assistance qualifications. Prescription Hope can keep you informed about program criteria and who qualifies for Merilog assistance. However, most programs normally set requirements in some specific areas:

Income: Each program sets its own qualifications for what a qualified patient’s income status should be.

Insurance: Each program also sets its own qualifications for what a qualified patient’s insurance coverage status should be.

Prescription: Every prescription assistance program requires a valid prescription for the patient’s intended name-brand medication.

U.S. Residency: In order to qualify, patients must be legal residents of the United States.

Simple Enrollment With Expert Support

Getting Started With Enrollment

Are you looking for help with the Merilog application process? Does the idea of navigating the Merilog application process seem daunting? Prescription Hope is ready to help you access prescription support services in 6 easy steps:

  1. Submit Information: Our online enrollment form takes just a few minutes out of your day to complete.
  2. Advocate Contact: After we receive your online enrollment form, a patient advocate will contact you in 1-2 business days.
  3. Document Collection: After your prequalification, our team will collect any necessary documents.
  4. Provider Coordination: We will also coordinate with your provider to obtain any signatures that are needed.
  5. Program Submission: We will put everything in order and send in your application for you, while continuing to coordinate with the pharmaceutical manufacturer.
  6. Medication Delivery: Following approval, qualified patients normally receive their medications in 1-2 weeks. All medications are shipped directly from the pharmaceutical manufacturer to the patient’s door or doctor’s office.

Understanding Merilog

How Merilog Works

Merilog contains insulin aspart-szjj, a rapid-acting human insulin analog.

Insulin aspart-szjj lowers blood glucose by facilitating cellular glucose uptake, inhibiting hepatic glucose production, and suppressing lipolysis and proteolysis.

Following subcutaneous injection, insulin aspart is rapidly absorbed, allowing it to begin lowering blood glucose within minutes of administration. Merilog has been demonstrated to be biosimilar to NovoLog® (insulin aspart), meaning there are no clinically meaningful differences in safety, purity, or potency from the reference product.

What Conditions Does Merilog Treat?

Merilog is FDA-approved to improve glycemic control in adults and pediatric patients with diabetes mellitus.

Merilog is a rapid-acting insulin used to help control blood glucose levels during meals. It is commonly used as part of an insulin regimen that may also include an intermediate-acting or long-acting insulin, depending on the individual’s treatment plan.

Merilog is the first FDA-approved rapid-acting insulin biosimilar in the United States.

Benefits of Treatment

For appropriate patients with diabetes, Merilog may:

  • Improve overall blood glucose control
  • Reduce post-meal (postprandial) blood glucose elevations
  • Provide rapid mealtime insulin coverage
  • Be used in both adults and pediatric patients with diabetes
  • Offer a biosimilar alternative to NovoLog® for appropriate patients when prescribed by a healthcare provider

Insulin therapy should always be individualized based on blood glucose monitoring, diet, physical activity, and patient-specific treatment goals.

Important Safety Information and Side Effects

Merilog does not carry an FDA Boxed Warning.

Contraindications

Merilog is contraindicated:

  • During episodes of hypoglycemia
  • In patients with hypersensitivity to insulin aspart products or any component of Merilog

The most commonly reported adverse reactions include:

  • Hypoglycemia (low blood sugar)
  • Injection site reactions
  • Lipodystrophy
  • Localized cutaneous amyloidosis
  • Weight gain
  • Peripheral edema (swelling of the hands or feet)
  • Rash

Additional insulin-related adverse reactions may include:

  • Hypersensitivity reactions
  • Hypokalemia (low potassium)

Patients should notify their healthcare provider if side effects become severe or persistent.

Patients should discuss the following risks with their healthcare provider:

  • Severe hypoglycemia
  • Hyperglycemia or hypoglycemia associated with changes in insulin regimen
  • Hyperglycemia and diabetic ketoacidosis resulting from inadequate insulin dosing or interruption of therapy
  • Medication errors caused by confusing different insulin products
  • Serious hypersensitivity reactions, including anaphylaxis
  • Hypokalemia
  • Fluid retention and heart failure when used with PPAR-gamma agonists (such as thiazolidinediones)
  • Lipodystrophy and localized cutaneous amyloidosis from repeated injections into the same site
  • Never share needles or syringes between patients, even if the needle is changed

Patients should carefully follow prescribed dosing instructions and monitor blood glucose regularly to reduce the risk of serious complications.

Available human data with insulin aspart have not identified a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. Maintaining good glycemic control before and during pregnancy is important to reduce diabetes-related risks.

Insulin is present in human milk. Available information suggests insulin therapy is compatible with breastfeeding, although insulin requirements may change during lactation. Patients should discuss any insulin dose adjustments with their healthcare provider.

Merilog may interact with:

  • Other antidiabetic medications
  • Corticosteroids
  • Diuretics
  • ACE inhibitors
  • MAO inhibitors
  • Beta-blockers (may mask symptoms of hypoglycemia)
  • Sympatholytic medications (may mask signs and symptoms of hypoglycemia)
  • Alcohol
  • Pentamidine
  • Clonidine
  • Lithium salts
  • Thiazolidinediones (may increase the risk of heart failure when combined with insulin)

Patients should inform their healthcare provider about all prescription medications, over-the-counter medicines, vitamins, and herbal supplements before starting treatment.

Merilog is administered by subcutaneous injection and should be injected within 5 to 10 minutes before the start of a meal. It is available as a 10 mL multidose vial (100 units/mL). Injection sites include the abdomen, thigh, upper arm, and buttocks, and sites should be rotated to reduce the risk of lipodystrophy and localized cutaneous amyloidosis. Merilog is generally used as part of a treatment regimen that also includes an intermediate-acting or long-acting insulin. It should not be mixed with other insulins when administered by continuous subcutaneous insulin infusion (insulin pump). When administered by subcutaneous injection, mixing instructions should follow the FDA-approved prescribing information and healthcare provider guidance.

Access to Multiple Medications

Support Beyond Merilog

Are you in need of further help with your prescription medication access? Are you in need of multiple medication assistance programs? Look no further than Prescription Hope!

Our prescription medication access services are available for hundreds of name-brand medications and their associated patient assistance programs. This means that every name-brand medication a qualified patient needs can be obtained at the same low service rate of $70.00 per month, per medication.

Why Choose Prescription Hope

Patient-Focused Medication Support

For 20 years, Prescription Hope has offered prescription affordability support and patient-centered prescription help to qualified patients across the nation. We are proud to say that we offer Merilog assistance through Prescription Hope.

Simplified Access to Prescription Medications

Prescription Hope offers all their medication access support and patient assistance services for a low monthly cost of $70.00 per month, per medication. There are no add-ons, no medication costs, no long contracts, and no hidden fees.

Ongoing Prescription Assistance

Prescription Hope’s help with prescription affordability programs doesn’t end when you receive your medication. We come by your side throughout treatment, offering our qualified patients long-term medication support. We continue to manage all administrative tasks to assist your continued status with a patient assistance program, such as refill scheduling, document updates, yearly renewals, and more.

Network Access

Our network extends across hundreds of name-brand medications and the patient assistance programs that go with them, offering you access to whatever medication you may need.

If you need Merilog and you don’t know how you’re going to afford it, enroll with Prescription Hope to see how we can help you save money today!

Frequently Asked Questions

It's Easy!

Submit Enrollment Form

Getting started is free and easy! Simply complete the online enrollment form. 

Receive Welcome Call

An Enrollment Specialist will reach out to you for a personalized welcome call.

We Manage The Process

Your dedicated team manages your account month after month, allowing you to focus on what matters most—your health.

Helpful Articles

Latest News & Stories

Save Money On Your Prescriptions Today!